The Foundation Dedicated to Discovering a Cure for Neuroendocrine Cancer

Caring for Carcinoid Foundation
Sign-up for our e-Newsletter.

Make a Difference - Get Involved Today
CFCF Photo
Clinical trials
Reasons to be Hopeful
Create Change Join Team CFCF
CFCF Photo
Newly Diagnosed?
The latest in carcinoid and pancreatic neuroendocrine cancer research

See how you can make a difference
Donate Now

07/18 New Article Suggests Effectiveness of Drug for Prolonged Progression-Free Survival

An article published in New England Journal of Medicine suggests the effectiveness of Somatuline(R) Depot (R) (lanreotide) in prolonged “progression-free survival” for more than 65 percent of patients who took it in a late-stage clinical trial, conducted at 48 sites in 14 countries.

06/10 Agenda Now Available for 2014 LA Patient Education Conference

The agenda is now available for CFCF's 2014 LA Patient Education Program. 

To view the agenda, click here. 

To register for the event, click here

05/06 2014 Los Angeles Patient Education Event

The Caring for Carcinoid Foundation (CFCF) is dedicated to empowering patients and equipping them with a comprehensive understanding of treatment options so they can make the best informed decisions when deciding their care. In this spirit, CFCF is pleased to bring together our extensive community of patients, loved ones, medical professionals, and supporters for the 6th Annual Los Angeles Patient Seminar on Saturday, June 21, 2014.

Please join us for this half day conference to learn more about the latest in neuroendocrine cancer diagnosis and treatment. Expert speakers will give brief lectures and then answer questions from patients and caregivers in a moderated discussion.

04/03 Orphan Drug Designation for Gallium-68
The radiopharmaceutical Gallium-68 (DOTA0-hel-Tyr3) octreotide (Ga-68 DOTATOC) has been designated as an orphan drug by the US Food and Drug Administration (FDA) for the management of neuroendocrine tumors.


Latest Video

Check out the CFCF video library.


Ron's Blog

Read the latest blog from CFCF's Executive Director.


Lauren's Blog

Read the latest blog from CFCF's Director of Research.

Seal Exchange      


We will be hosting a ride/run where the participants can choose either a 25 mile bike ride OR 5K run/walk to bring awareness to NET's/PNET's. 100% of registration fee goes directly to CFCF.

Connect with CFCF online:

The passing of Steve Jobs is a powerful reminder of the need for funding for research to find a cure for Pancreatic Neuroendocrine and other neuroendocrine cancers.